• 10495 Citations
  • 54 h-Index
1966 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 4 Similar Profiles
Tretoquinol Medicine & Life Sciences
Adrenergic Receptors Medicine & Life Sciences
Androgen Receptors Medicine & Life Sciences
Imidazolines Medicine & Life Sciences
Tetrahydroisoquinolines Medicine & Life Sciences
Tubulin Modulators Medicine & Life Sciences
Structure-Activity Relationship Medicine & Life Sciences
Ligands Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1966 2019

1 Citation (Scopus)

Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy

Arnst, K. E., Banerjee, S., Chen, H., Deng, S., Hwang, D. J., Li, W. & Miller, D., Jan 1 2019, In : Medicinal Research Reviews.

Research output: Contribution to journalReview article

Tubulin Modulators
Pharmaceutical Preparations

New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity

Hwang, D. J., He, Y., Ponnusamy, S., Mohler, M. L., Thiyagarajan, T., McEwan, I. J., Narayanan, R. & Miller, D., Jan 24 2019, In : Journal of Medicinal Chemistry. 62, 2, p. 491-511 21 p.

Research output: Contribution to journalArticle

Androgen Receptors
Prostatic Neoplasms
Androgen Receptor Antagonists

Therapeutic efficacy of a novel βiII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer

Kashyap, V. K., Wang, Q., Setua, S., Nagesh, P. K. B., Chauhan, N., Kumari, S., Chowdhury, P., Miller, D., Yallapu, M., Li, W., Jaggi, M., Hafeez, B. & Chauhan, S., Jan 23 2019, In : Journal of Experimental and Clinical Cancer Research. 38, 1, 29.

Research output: Contribution to journalArticle

Tubulin Modulators
Pancreatic Neoplasms
Protein Isoforms
14 Citations (Scopus)

A potent, metabolically stable tubulin inhibitor targets the colchicine binding site and overcomes taxane resistance

Arnst, K. E., Wang, Y., Hwang, D. J., Xue, Y., Costello, T., Hamilton, D., Chen, Q., Yang, J., Park, F., Dalton, J. T., Miller, D. & Li, W., Jan 1 2018, In : Cancer Research. 78, 1, p. 265-277 13 p.

Research output: Contribution to journalArticle

Tubulin Modulators
Binding Sites
1 Citation (Scopus)

Computationally identified novel agonists for GPRC6A

Pi, M., Kapoor, K., Ye, R., Hwang, D. J., Miller, D., Smith, J. C., Baudry, J. & Quarles, L., Apr 1 2018, In : PloS one. 13, 4, e0195980.

Research output: Contribution to journalArticle

insulin secretion
Medical problems
noninsulin-dependent diabetes mellitus